About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Bmpr2
bone morphogenetic protein receptor type 2
MGI:1095407
75 phenotypes from 9 alleles in 12 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Bmpr2b2b2556Clo/Bmpr2b2b2556Clo
C57BL/6J-Bmpr2b2b2556Clo
abnormal myocardium compact layer morphology J:175213
abnormal semilunar valve morphology J:175213
atrioventricular septal defect J:175213
hydronephrosis J:175213
muscular ventricular septal defect J:175213
persistent truncus arteriosus type i J:175213
persistent truncus arteriosus type iv J:175213
Bmpr2tm1.1Enl/Bmpr2tm1.1Enl
involves: 129S4/SvJae * C57BL/6 * FVB/N
no abnormal phenotype detected J:97109
Bmpr2tm1.1Enl/Bmpr2tm1.1Enl
Tg(Acvrl1-cre)L1Spo/0
involves: 129S4/SvJae * FVB
abnormal lung thrombosis J:158116
abnormal lung vasculature morphology J:158116
abnormal pulmonary artery morphology J:158116
artery occlusion J:158116
heart right ventricle hypertrophy J:158116
increased lung endothelial cell proliferation J:158116
increased pulmonary artery pressure J:158116
increased vascular smooth muscle cell proliferation J:158116
pulmonary hypertension J:158116
Bmpr2tm1.1Enl/Bmpr2tm1.1Enl
Tg(KRT14-cre)1Ipc/0
involves: 129S4/SvJae * C57BL/6 * SJL
abnormal hair medulla J:189569
abnormal hair medullary septa cells J:189569
abnormal hair shaft melanin granule distribution J:189569
normal integument phenotype J:189569
Bmpr2tm1.1Enl/Bmpr2tm1.2Enl
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129S4/SvJae * C57BL/6J * CBA/J
abnormal ophthalmic nerve morphology J:206541
normal nervous system phenotype J:206541
Bmpr2tm1.1Enl/Bmpr2tm1Kmi
Tg(KRT14-cre)1Ipc/0
involves: 129S4/SvJae * C57BL/6 * SJL
no abnormal phenotype detected J:189569
Bmpr2tm1.1Pley/Bmpr2+
B6.Cg-Bmpr2tm1.1Pley
normal cardiovascular system phenotype J:209027
Bmpr2tm1.1Pley/Bmpr2tm1.1Pley
B6.Cg-Bmpr2tm1.1Pley
embryonic lethality between implantation and placentation, incomplete penetrance J:209027
Bmpr2tm1.2Enl/Bmpr2tm1.2Enl
involves: 129S4/SvJae * C57BL/6
embryonic growth retardation J:97109
embryonic lethality between implantation and somite formation, complete penetrance J:97109
Bmpr2tm1Enl/Bmpr2tm1Enl
involves: 129S4/SvJae * C57BL/6
no abnormal phenotype detected J:97109
Bmpr2tm1Kmi/Bmpr2+
involves: 129S4/SvJae
abnormal sternocostal joint morphology J:95124
vertebral transformation J:95124
Bmpr2tm1Kmi/Bmpr2+
involves: 129S4/SvJae * C57BL/6
abnormal lung vasculature morphology J:98219
abnormal pulmonary alveolus morphology J:98219
abnormal pulmonary artery morphology J:98219
increased pulmonary artery pressure J:98219
increased pulmonary vascular resistance J:98219
pulmonary hypertension J:98219
Bmpr2tm1Kmi/Bmpr2+
involves: 129S4/SvJae * C57BL/6J
abnormal leukocyte physiology J:117167
abnormal lung vasculature morphology J:117167
increased vasoconstriction J:117167
perinatal lethality, incomplete penetrance J:117167
prenatal lethality, incomplete penetrance J:117167
pulmonary hypertension J:117167
Bmpr2tm1Kmi/Bmpr2tm1Kmi
involves: 129S4/SvJae * C57BL/6J
abnormal egg cylinder morphology J:61931
abnormal embryonic epiblast morphology J:61931
abnormal embryonic-extraembryonic boundary morphology J:61931
abnormal rostral-caudal axis patterning J:61931
absent mesoderm J:61931
disorganized embryonic tissue J:61931
disorganized extraembryonic tissue J:61931
embryonic growth arrest J:61931
embryonic growth retardation J:61931
embryonic lethality during organogenesis, complete penetrance J:61931
failure of primitive streak formation J:61931
failure to gastrulate J:61931
Bmpr2tm1Kml/Bmpr2tm1Kml
either: (involves: 129X1/SvJ * BALB/cJ) or (involves: 129X1/SvJ * C57BL/6J)
abnormal interventricular septum morphology J:80024
abnormal semilunar valve morphology J:80024
absent vitelline blood vessels J:80024
decreased rib number J:80024
delayed bone ossification J:80024
interrupted aortic arch J:80024
lethality throughout fetal growth and development, complete penetrance J:80024
Bmpr2tm1Mmue/Bmpr2+
B6.129S1-Bmpr2tm1Mmue
abnormal pulmonary artery morphology J:224752
increased right ventricle systolic pressure J:224752
increased vascular permeability J:224752
pulmonary hypertension J:224752
Bmpr2tm1Mmue/Bmpr2tm1Mmue
B6.129S1-Bmpr2tm1Mmue
lethality, complete penetrance J:224752
Gt(ROSA)26Sortm1(RNAi:Bmpr2)Dliu/Gt(ROSA)26Sor+
involves: 129 * C57BL/6J
abnormal blood vessel morphology J:145514
abnormal pulmonary artery morphology J:145514
abnormal spleen morphology J:145514
abnormal spleen white pulp morphology J:145514
anemia J:145514
cachexia J:145514
decreased angiogenesis J:145514
decreased erythrocyte cell number J:145514
enlarged spleen J:145514
extramedullary hematopoiesis J:145514
normal homeostasis/metabolism phenotype J:145514
intestinal hemorrhage J:145514
intestine polyps J:145514
pallor J:145514
premature death J:145514
respiratory distress J:145514
reticulocytosis J:145514
normal skeleton phenotype J:145514
vascular smooth muscle hypoplasia J:145514
Gt(ROSA)26Sortm1(RNAi:Bmpr2)Dliu/Gt(ROSA)26Sortm1(RNAi:Bmpr2)Dliu
involves: 129 * C57BL/6J
gastrointestinal hemorrhage J:145514
premature death J:145514
Tg(Tagln-rtTA)E1Jwst/0
Tg(tetO-Bmpr2*R899X)#Jwst/0
involves: FVB/N
abnormal lung vasculature morphology J:164503
heart right ventricle hypertrophy J:164503
increased body weight J:164503
increased right ventricle systolic pressure J:164503

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/05/2024
MGI 6.24
The Jackson Laboratory